Gemcitabine and CT-011 for Resected Pancreatic Cancer
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
Safety and Efficacy Study of Five-fraction Stereotactic Body Radiation Therapy to Locally Advanced Pancreatic Cancer
Combination of Stereotactic Body Radiation Therapy With S-1 for Treating Locally Advanced Pancreatic Cancer
|6||Not yet recruiting||
Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer
† Study has passed its completion date and status has not been verified in more than two years.